Rosecrance, Inc. | |
2302 Moreland Blvd Champaign IL 61822-1398 | |
(217) 356-7576 | |
Not Available |
Full Name | Rosecrance, Inc. |
---|---|
Speciality | Clinic/center - Mental Health (including Community Mental Health Center) |
Location | 2302 Moreland Blvd, Champaign, Illinois |
Authorized Official Name and Position | Rachel Sheets (MANAGED CARE CONTRACTING ASSISTANT) |
Authorized Official Contact | 8153875680 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
Rosecrance, Inc. 1020 N Mulford Rd Rockford IL 61107-3858 Ph: () - | Rosecrance, Inc. 2302 Moreland Blvd Champaign IL 61822-1398 Ph: (217) 356-7576 |
NPI Number | 1083104558 |
---|---|
Provider Enumeration Date | 05/10/2018 |
Last Update Date | 01/04/2019 |
Identifier | Type | State | Issuer |
---|---|---|---|
1083104558 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
261QM0801X | Clinic/center - Mental Health (including Community Mental Health Center) | (* (Not Available)) | Primary |
News Archive
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced that it has entered into an exclusive US $75 million license agreement with Kissei Pharmaceutical Co., Ltd. for the development and commercialization of its PSA-activated pro-drug, PRX302, in Japan for BPH, prostate cancer and other diseases of the prostate. Protox retains exclusive rights to PRX302 in all other territories.
Younger teenagers in the South West of England felt less anxious and more connected to school when they were away from it during the COVID-19 global pandemic public lockdown, a first-of-its-kind study has found.
Our immune system has various ways to deal with threats from the outside like pathogens. One of the defence mechanisms is a process called autophagy.
Despite disproportionately higher rates of COVID-19 infection, hospitalization and death among people of color, minority groups are significantly underrepresented in COVID-19 clinical trials, according to a new perspective authored by faculty from the University of Georgia and University of Colorado and pharmacists from Phoebe Putney Memorial Hospital in Albany.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that preliminary results from its ENABLE Phase 2 proof-of-concept trial demonstrated that bafetinib, the Company's Bcr-Abl, Lyn and Fyn kinase inhibitor, was clinically active in a group of patients with relapsed or refractory B-cell chronic lymphocytic leukemia (B-CLL) who have failed several other treatments for their cancer.
› Verified 5 days ago
Creative Solutions, Pamela Wendt Counseling Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 116 N Chestnut St, Ste 220, Champaign, IL 61820 Phone: 217-202-9506 | |
Approachable Therapy Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 505 W University Ave Ste 211, Champaign, IL 61820 Phone: 217-398-3124 | |
Lawrence L Jeckel Md Pc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2500 Galen Drive, Champaign, IL 61821 Phone: 217-356-0228 Fax: 217-356-0667 | |
Lavina Velasco Counseling, Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2516 Waterville Dr, Champaign, IL 61822 Phone: 217-990-8309 | |
Doris Jenkins Counseling Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 701 Devonshire Dr Ste 102e, Champaign, IL 61820 Phone: 217-343-7707 | |
Julie Birky Counseling Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 206 N Randolph St, Champaign, IL 61820 Phone: 815-357-7280 | |
Bodhi Counseling & Consulting Center, Pc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 206 N Randolph St Ste 432, Champaign, IL 61820 Phone: 217-731-4638 |